Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HealthMarkets, Inc. (UCI)
|
|
| Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Commercial Health Division | 490.7 | 585.3 | 798.7 | | | | | |
| Insphere | 91.4 | 73.7 | 46.2 | | | | | |
| Corporate | 14.2 | 24.0 | 24.7 | | | | | |
| Disposed Operations | 0.2 | 1.6 | 2.4 | | | | | 2,121.2 |
| Total revenues | 568.3 | 665.2 | 861.7 | 1,083.4 | 1,300.4 | 1,382.2 | 1,737.2 | 1,917.5 |
| Revenue growth | -14.6% | -22.8% | -20.5% | -16.7% | -5.9% | -20.4% | -9.4% | 3.2% |
| Loss and loss adjustment expenses | 322.6 | 359.4 | 366.6 | 584.9 | | | | |
| Policy acquisition costs | 8.7 | 16.4 | 31.5 | | | | | |
| Investment expenses | 1.2 | 2.0 | 1.7 | | | | | |
| Other operating expenses | 229.8 | 241.8 | 336.6 | 436.8 | 1,340.6 | 1,213.3 | 1,351.6 | 1,598.4 |
| General and administrative | 44.2 | 43.8 | 68.7 | | | | | |
| EBITDA | -29.4 | -9.5 | 46.0 | 92.6 | -24.0 | 103.3 | 244.6 | 234.1 |
| EBITDA margin | -5.2% | -1.4% | 5.3% | 8.5% | -1.8% | 7.5% | 14.1% | 12.2% |
| Depreciation | 13.7 | 17.2 | 23.2 | 30.9 | 29.7 | 33.9 | 28.0 | 31.2 |
| EBIT | -43.1 | -26.7 | 22.8 | 61.7 | -53.7 | 69.4 | 216.6 | 203.0 |
| EBIT margin | -7.6% | -4.0% | 2.6% | 5.7% | -4.1% | 5.0% | 12.5% | 10.6% |
| Interest expense, net [+] | -11.2 | -5.9 | -12.2 | 32.4 | 45.2 | 49.8 | 13.7 | 6.0 |
| Interest expense | 12.6 | 22.1 | 30.1 | 32.4 | 45.2 | 49.8 | 34.8 | 6.0 |
| Interest income | 23.9 | 28.0 | 42.2 | | | | 21.1 | |
| Pre-tax income | -6.7 | 23.4 | 95.1 | 29.2 | -85.4 | 119.1 | 350.9 | 313.2 |
| Income taxes | 0.6 | 9.7 | 36.5 | 11.5 | 0.0 | 0.0 | 0.0 | 109.6 |
| Tax rate | | 41.4% | 38.4% | 39.4% | 0.0% | 0.0% | 0.0% | 35.0% |
| Net income | -6.9 | 13.8 | 58.7 | 17.7 | 0.0 | 0.0 | 0.0 | 203.5 |
| Net margin | -1.2% | 2.1% | 6.8% | 1.6% | 0.0% | 0.0% | 0.0% | 10.6% |
| |
| Basic EPS | ($0.24) | $0.45 | $1.97 | $0.59 | | | | $4.41 |
| Diluted EPS | ($0.24) | $0.44 | $1.91 | $0.58 | | | | $4.32 |
| |
| Shares outstanding (basic) | 30.4 | 30.4 | 29.8 | 29.5 | | | | 46.1 |
| Shares outstanding (diluted) | 30.4 | 31.3 | 30.7 | 30.0 | | | | 47.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|